Document is current
Any future updates will be listed below
-
Authors
Hammer, Robert P. https://orcid.org/0009-0007-5962-5266
Butrie, Melissa A. https://orcid.org/0009-0003-7374-7690
Davidson, Karen https://orcid.org/0009-0005-1379-9004
Goldblatt, Phillip T. https://orcid.org/0009-0006-4210-1020
Schrader, Alex M. https://orcid.org/0009-0007-9800-3910
Dalluge, Joseph J. https://orcid.org/0000-0002-4492-6927
Becker, Allyn https://orcid.org/0009-0000-6196-4610
Barany, George https://orcid.org/0000-0002-6373-2706
- License Information
-
More Information
Article History
Accepted: 16 November 2023
First Online: 26 December 2023
Declarations
:
: None of the authors have competing interests that are relevant to the content of this article. None of the authors have any relevant financial interests to disclose. In the early 2010s, <i>although not overlapping with the duration of the sponsored support to his research program at the University of Minnesota</i>, GB consulted for Teva Parenteral Medicines, and received appropriate remuneration.
